Merck Mercuriadis, founder of the influential catalog investment group Hipgnosis, is preparing to launch a re-vamped version ...

Explore the Hipgnosis founder's new venture, focused on music management and co-ownership for artists and managers.

Merck Mercuriadis, the architect behind Hipgnosis’s transformation of music rights into a mainstream asset class, is making a ...

With a $10 billion deal for the Los Angeles Lakers, Guggenheim CEO Mark Walter is adding another trophy asset to a portfolio ...

From health to hair care, the experts broke down exactly how artificial intelligence is shaping Black futures and why we can’t afford to sit this one out.

Merck & Co., Inc. (NYSE: MRK) is one of the. The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for ...

Sean “Diddy” Combs would have a hard time launching a comeback despite his acquittal on the most severe charges because of ...

US pharmaceutical companies will be forced to answer questions this week from lawmakers, who have been grilling them on their ...

U.S. Health Secretary Robert F. Kennedy Jr.'s newly revamped vaccine advisory panel voted on Thursday to recommend Americans ...

A startling new vision of vaccination in America is becoming clearer — one likely to involve fresh scrutiny of established science and practices, and limits on vaccines that have been studied for ...

The CDC's Advisory Committee on Immunization Practices voted on the flu vaccine, raising concerns about a rarely used ...

The Trump administration’s new vaccine advisers on Thursday endorsed this fall’s flu vaccinations for just about every ...